Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023 at 06:00 AM EDT
Leqembi is the first Alzheimer's antibody treatment to receive full FDA approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
